Business Context and Reporting Period
Company: Burning Rock Biotech Ltd
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Date: March 12, 2026
Principal Executive Offices: No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China
This filing serves as a current report incorporating a press release (Exhibit 99.1) by reference into the Company's registration statements on Form F-3. The document excludes specific non-GAAP measures and reconciliation tables from the incorporated exhibit.
Key Financial Metrics
The provided filing text does not contain specific financial data. It is a cover document referencing an external press release. Consequently, the following metrics are not available in this text:
- Revenue
- Profit
- Cash Flow
- Margins
- Debt
- Liquidity
Material Changes
The filing text does not provide details on material changes versus prior periods. The substantive content regarding operational or financial changes is located in the referenced Exhibit 99.1 (Press Release), which is not included in the input text.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the provided text. The document strictly outlines the incorporation of the press release by reference and the signature of the Chief Executive Officer.
Investor Verification Checklist
- Verify the full content of Exhibit 99.1 (Press Release) to obtain the actual news or financial updates intended by this filing.
- Confirm the specific details of the incorporation by reference into the Form F-3 (File no. 333-264577).
- Note that non-GAAP measures and reconciliations are explicitly excluded from the incorporation by reference in this specific filing.
- Review the signature block to confirm authorization by Yusheng Han, Chief Executive Officer.